New York · J0885

Injection, Epoetin Alfa, (for Non-Esrd Use), 1000 Units in New York

New York Medicare Avg
$5.61
3% below national avg
National Medicare Avg
$5.78
All states combined
Billed Charge (NY)
$30.55
What providers submit
Est. Commercial (NY)
$17.80
National avg: $16.46
Est. Cash / Self-Pay (NY)
$13.74
Typical self-pay discount

Estimated using RAND 2024 commercial-to-Medicare ratios. Actual prices vary by insurer, plan, and facility.

316.9K
Services in NY
292
Providers
N/A
Min Payment
N/A
Max Payment

Top Providers in New York

Provider Medicare Services
Sikder, Manzurul MD $5.85 24.7K
Razia, Sultana M.D. $5.86 23.5K
Schoen, Lindsay NP $5.77 19.2K
Gupta, Salil M.D. $5.83 13.7K
Benkel, Seth M.D. $1.31 12.1K
Rao, Pawan M.D. $5.87 10.1K
Fulman, Malvina M.D. $5.83 10.1K

New York Pricing in Context

In New York, CPT code J0885 (Injection, Epoetin Alfa, (for Non-Esrd Use), 1000 Units) carries an average Medicare payment of $5.61 — 3% below the national benchmark of $5.78. 292 providers across the state submitted claims for this procedure in 2023, performing 316.9K total services. Individual payments in NY ranged from N/A at the low end to N/A at the high end, reflecting differences in provider setting (office vs. facility), modifiers, and the specific geographic locality code applied within the state.

The average billed charge in New York is $30.55, which is the figure uninsured patients would most likely encounter before any negotiation or charity discount. Medicare, by statute, only reimburses the allowed amount — the balance between billed and paid is written off under provider participation agreements. Insured patients generally pay a negotiated rate that falls between these two figures; the exact amount depends on plan design, deductible status, and in-network participation. Because New York sits below the national Medicare average, commercial rates in the state may also run lower than the US median.

Using RAND 2024 commercial-to-Medicare ratios for Drugs (Administered) procedures, the estimated commercial insurance price in New York lands near $17.80, with self-pay cash prices typically around $13.74. Before scheduling, patients can request a Good Faith Estimate under the No Surprises Act, compare cash rates from hospital Machine-Readable Files, and confirm whether the provider is in-network with their specific plan. This page presents CMS reference data for informational use; it does not constitute medical or financial advice.

Frequently Asked Questions

How much does Injection, Epoetin Alfa, (for Non-Esrd Use), 1000 Units cost in New York?

The average Medicare payment for Injection, Epoetin Alfa, (for Non-Esrd Use), 1000 Units in New York is $5.61, which is 3% below the national average of $5.78. Providers in NY typically bill $30.55 for this procedure.

What does Injection, Epoetin Alfa, (for Non-Esrd Use), 1000 Units cost with insurance in New York?

With commercial insurance in New York, Injection, Epoetin Alfa, (for Non-Esrd Use), 1000 Units costs an estimated $17.80. Without insurance, the estimated cash price is $13.74. These estimates are based on RAND 2024 commercial-to-Medicare ratios and vary by insurer, plan, and facility.

How many providers perform Injection, Epoetin Alfa, (for Non-Esrd Use), 1000 Units in New York?

292 providers in New York billed Medicare for Injection, Epoetin Alfa, (for Non-Esrd Use), 1000 Units in 2023, performing 316.9K total services. Medicare payments ranged from N/A to N/A depending on the provider.

Is Injection, Epoetin Alfa, (for Non-Esrd Use), 1000 Units cheaper in New York than the national average?

Yes — Injection, Epoetin Alfa, (for Non-Esrd Use), 1000 Units costs 3% below the national average in New York. The state average Medicare payment is $5.61 compared to $5.78 nationally. Factors like local cost of living, provider competition, and regional Medicare fee schedules all influence state-level pricing.

Related

Data sourced from the CMS Medicare Physician and Other Practitioners dataset. See our methodology for details. Retrieved and formatted by PlainProcedure Editorial